German Cannabis Legalization

Still Growth Potential With the developments since the implementation of the Cannabis Act (CanG), the medicinal cannabis industry has so far been the clear winner of decriminalization in Germany. Before April 1, it was estimated that there were between 200,000 and 300,000 cannabis patients in Germany. The exact number is difficult to determine due to […]

Since the enactment of the Cannabis Act (CanG) six weeks ago, which allows adults to consume and possess limited amounts of the drug, there have been demands for the implementation of the so-called “second pillar.” Federal Drug Commissioner Burkhard Blienert is calling for a quick start of model trials for commerce to counteract the black

Background: New Cannabis Legislation Faces Criticism The German government has introduced a new draft law that aims to fulfill the promises made in the Bundesrat regarding the Cannabis Act. However, this proposal has faced considerable backlash due to concerns about its restrictive nature. On April 16, the Federal Ministry of Health (BMG) introduced the draft

This Wednesday witnessed a pivotal moment in German drug policy as the cannabis law, recently passed by the Bundestag, was officially presented to Manuela Schwesig, President of the Bundesrat, for signing. Representing the vacationing Federal President Frank-Walter Steinmeier, Schwesig’s endorsement of the document was anticipated, despite her own expressed reservations. This step marks a historic

As the global cannabis industry continues to evolve, Germany’s move towards partial legalization of cannabis has caught the attention of startups and industry participants worldwide. Scheduled initially for April 1st, this legislative shift aims to regulate cannabis possession and cultivation for adult personal use under stringent conditions. Here’s a structured breakdown of the developments, concerns,

In the realm of global cannabis policy, a notable development has unfolded, placing Germany’s cannabis legalization efforts under scrutiny by the International Narcotics Control Board (INCB), a pivotal entity of the United Nations. This recent announcement holds significant implications for cannabis founders and investors, indicating a critical juncture in the ongoing debate between national legislative

As Germany stands on the cusp of a landmark decision, with the Bundestag slated to vote on the legalization of cannabis at 1 PM today, it’s an opportune moment to reflect on the transformative potential this industry holds not just for recreational and medicinal use, but for the broader agricultural sector and the pressing issue

February 21, 2024 – In a historic move that is set to redefine the cannabis landscape in Europe, the German Health Committee, along with all advisory committees, has approved the Cannabis Act (CanG), marking the biggest drug policy advancement in the Federal Republic’s history. This critical step, taken on February 21, 2024, clears the path

BERLIN — In a pivotal development that marks a significant shift in Germany’s drug policy, the governing coalition has overcome internal disagreements on the cannabis legalization initiative, setting the stage for a new era in the cannabis industry. The legislative proposal, aimed at decriminalizing cannabis, is poised to be enacted on April 1, following confirmation